Literature DB >> 16312150

Biosynthetic engineering of natural products for lead optimization and development.

Barrie Wilkinson1, Steven J Moss.   

Abstract

It is now possible to rapidly and rationally modify, at a genetic level, the machinery responsible for natural product biosynthesis. This provides the opportunity to design new structures and to optimize natural product lead compounds in a way that would be extremely difficult through synthetic chemistry means alone. The technology can also be used to overcome limitations of compound supply, which might otherwise preclude natural products from progressing into clinical trials. Described herein are some recent examples which highlight how biosynthetic engineering has been applied to drug discovery and development, and which attempt, in particular, to demonstrate how the technology functions most effectively when combined with synthetic organic and medicinal chemistry.

Mesh:

Substances:

Year:  2005        PMID: 16312150

Source DB:  PubMed          Journal:  Curr Opin Drug Discov Devel        ISSN: 1367-6733


  3 in total

1.  Exploiting enzymatic promiscuity to engineer a focused library of highly selective antifungal and antiproliferative aureothin analogues.

Authors:  Martina Werneburg; Benjamin Busch; Jing He; Martin E A Richter; Longkuan Xiang; Bradley S Moore; Martin Roth; Hans-Martin Dahse; Christian Hertweck
Journal:  J Am Chem Soc       Date:  2010-08-04       Impact factor: 15.419

2.  Diversity oriented biosynthesis via accelerated evolution of modular gene clusters.

Authors:  Aleksandra Wlodek; Steve G Kendrew; Nigel J Coates; Adam Hold; Joanna Pogwizd; Steven Rudder; Lesley S Sheehan; Sarah J Higginbotham; Anna E Stanley-Smith; Tony Warneck; Mohammad Nur-E-Alam; Markus Radzom; Christine J Martin; Lois Overvoorde; Markiyan Samborskyy; Silke Alt; Daniel Heine; Guy T Carter; Edmund I Graziani; Frank E Koehn; Leonard McDonald; Alexander Alanine; Rosa María Rodríguez Sarmiento; Suzan Keen Chao; Hasane Ratni; Lucinda Steward; Isobel H Norville; Mitali Sarkar-Tyson; Steven J Moss; Peter F Leadlay; Barrie Wilkinson; Matthew A Gregory
Journal:  Nat Commun       Date:  2017-10-31       Impact factor: 17.694

3.  An Amidinohydrolase Provides the Missing Link in the Biosynthesis of Amino Marginolactone Antibiotics.

Authors:  Hui Hong; Markiyan Samborskyy; Frederick Lindner; Peter F Leadlay
Journal:  Angew Chem Int Ed Engl       Date:  2015-12-02       Impact factor: 15.336

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.